BioNTech SE (BNTX) Tops Q3 EPS by 236c

Go back to BioNTech SE (BNTX) Tops Q3 EPS by 236c

BioNTech (BNTX) PT Raised to $126 at BMO Capital

November 4, 2024 4:06 PM EST

BMO Capital analyst Etzer Darout raised the price target on BioNTech (NASDAQ: BNTX) to $126.00 (from $122.00) while maintaining a Outperform rating.

The analyst comments "BNTX announced revenues of 1.24B, above FactSet consensus (+142%) and reiterated FY24 guidance of 2.5-3.1B in revenues,... More